Comparison of intuitiveness, ease of use and preference among three prefilled, disposable growth hormone injection pens

Bibliography

• Miller BS. rhGH safety and efficacy update. Adv Pediatr 2011;58:207-41
   PubMedGoogle Scholar
• Sas T, de Ridder MAJ, Wit JM, et al. Adult height in children with growth hormone deficiency: a randomized, controlled, growth hormone, dose response trial. Horm Res Paediatr 2010;74:172-81
   PubMed Web of Science ®Google Scholar
• Reiter EO, Price DA, Wilton P, et al. Effect of growth hormone (GH) treatment on the near-final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database. J Clin Endocrinol Metab 2006;91:2047-54
   PubMed Web of Science ®Google Scholar
• Van Pareren YK, de Muinck Keizer-Schrama SMPF, Stijnen T, et al. Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab 2003;88:1119-25
   PubMed Web of Science ®Google Scholar
• Bannink EM, van Doorn J, Mulder PG, Hokken-Koelega AC. Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age. J Clin Endocrinol Metab 2007;92:2992-3000
   PubMed Web of Science ®Google Scholar
• Thier SL, Yu-Isenberg KS, Leas BF, et al. In chronic disease, nationwide data show poor adherence by patients to medication and by physicians to guidelines. Manag Care 2008;17:48-52. 55–7
   PubMedGoogle Scholar
• Kapoor RR, Burke SA, Sparrow SE, et al. Monitoring of concordance in growth hormone therapy. Arch Dis Child 2008;93:147-8
   PubMed Web of Science ®Google Scholar
• Cutfield WS, Derraik JG, Gunn AJ, et al. Non-compliance with growth hormone treatment in children is common and impairs linear growth. PLoS One 2011;6:e16223
   PubMed Web of Science ®Google Scholar
• Smith SL, Hindmarsh PC, Brook CG. Compliance with growth hormone treatment – are they getting it? Arch Dis Child 1993;68:91-3
   PubMed Web of Science ®Google Scholar
• Rosenfeld RG, Bakker B. Compliance and persistence in pediatric and adult patients receiving growth hormone therapy. Endocr Pract 2008;14:143-54
   PubMedGoogle Scholar
• Desrosiers P, O'Brien F, Biethen S. Patient outcomes in the GH monitor: the effect of delivery device on compliance and growth. Pediatr Endocrinol Rev 2005;2(Suppl 3):327-31
   PubMedGoogle Scholar
• Haverkamp F, Johansson L, Dumas H, et al. Observations of nonadherence to recombinant human growth hormone therapy in clinical practice. Clin Ther 2008;30:307-16
   PubMed Web of Science ®Google Scholar
• Kremidas D, Wisniewski T, Divino VM, et al. Administration burden associated with recombinant human growth hormone treatment: perspectives of patients and caregivers. J Pediatr Nurs 2012;28:55-63
   PubMedGoogle Scholar
• Haverkamp F, Gasteyger C. A review of biopsychosocial strategies to prevent and overcome early-recognized poor adherence in growth hormone therapy of children. J Med Econ 2011;14:448-57
   PubMedGoogle Scholar
• Fidotti E. A history of growth hormone injection devices. J Pediatr Endocrinol Metab 2001;14:497-501
   PubMed Web of Science ®Google Scholar
• Main KM, Jørgensen JT, Hertel NT, et al. Automatic needle insertion diminishes pain during growth hormone injection. Acta Paediatr 1995;84:331-4
   PubMed Web of Science ®Google Scholar
• Albertsson-Wikland K. Simplified growth hormone therapy – first clinical experience with the KabiPen. Acta Paediatr Scand Suppl 1988;343:103-6
   PubMedGoogle Scholar
• Jørgensen JT. Improvement of patient convenience in treatment with growth hormone. J Pediatr Endocrinol 1994;7:175-80
   PubMed Web of Science ®Google Scholar
• Oyarzabal M, Aliaga M, Chueca M, et al. Multicentre survey on compliance with growth hormone therapy: what can be improved? Acta Paediatr 1998;87:387-91
   PubMed Web of Science ®Google Scholar
• Dumas H, Panayiotopoulos P, Parker D, Pongpairochana V. Understanding and meeting the needs of those using growth hormone injection devices. BMC Endocr Disord 2006;6:5
   PubMedGoogle Scholar
• Fuchs GS, Mikkelsen S, Knudsen TK, Kappelgaard AM. Ease of use and acceptability of a new pen device for the administration of growth hormone therapy in pediatric patients: an open-label, uncontrolled usability test. Clin Ther 2009;31:2906-14
   PubMed Web of Science ®Google Scholar
• Pfützner A, Hartmann K, Winter F, et al. Intuitiveness, ease of use, and preference of a prefilled growth hormone injection pen: a noninterventional, randomized, open-label, crossover, comparative usability study of three delivery devices in growth hormone-treated pediatric patients. Clin Ther 2010;32:1918-34
   PubMed Web of Science ®Google Scholar
• Kappelgaard AM, Mikkelsen S, Knudsen TK, Fuchs GS. Patient preference for a new growth hormone injection device: results of an open-label study in Japanese pediatric patients. J Pediatr Endocrinol Metab 2011;24:489-96
   PubMed Web of Science ®Google Scholar
• Kappelgaard AM, Mikkelsen S, Bagger C, Fuchs GS. Children and adolescent acceptability of a new device system to administer human growth hormone. J Pediatric Endocrinol Metab 2012;25:285-94
   PubMed Web of Science ®Google Scholar
• World Medical Association Declaration of Helsinki. Available from: http://www.wma.net/en/30publications/10policies/b3/17c.pdf [Accessed September 2012]
   Google Scholar
• International Conference for Harmonisation of Technical Requirements of Pharmaceuticals for Human Use (ICH) Guideline for Good Clinical Practice E6 (R1). Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6_R1/Step4/E6_R1__Guideline.pdf [Accessed September 2012]
   Google Scholar
• Nickman NA, Haak SW, Kim J. Cost minimization analysis of different growth hormone pen devices based on time-and-motion simulations. BMC Nurs 2010;9:6
   PubMedGoogle Scholar
• Norgren S. Adherence remains a challenge for patients receiving growth hormone therapy. Pediatr Endocrinol Rev 2009(Suppl 4):545-8
   PubMedGoogle Scholar
• Wickramasuriya BP, Casey A, Akhtar S, et al. Factors determining patient choice of device for GH therapy. Horm Res 2006;65:18-22
   PubMed Web of Science ®Google Scholar
• van Dongen N, Kaptein AA. Parents' views on growth hormone treatment for their children: psychosocial issues. Patient Prefer Adherence 2012;6:547-53
   PubMed Web of Science ®Google Scholar
• Lee WC, Balu S, Cobden D, et al. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther 2006;28:1712-25b
   PubMed Web of Science ®Google Scholar